4.14
price down icon0.48%   -0.02
after-market Handel nachbörslich: 4.17 0.03 +0.72%
loading
Schlusskurs vom Vortag:
$4.16
Offen:
$4.1
24-Stunden-Volumen:
2.70M
Relative Volume:
0.64
Marktkapitalisierung:
$408.12M
Einnahmen:
$775.09M
Nettoeinkommen (Verlust:
$-58.68M
KGV:
-31.22
EPS:
-0.1326
Netto-Cashflow:
$64.06M
1W Leistung:
-5.69%
1M Leistung:
-1.19%
6M Leistung:
-7.80%
1J Leistung:
-40.09%
1-Tages-Spanne:
Value
$3.95
$4.23
1-Wochen-Bereich:
Value
$3.95
$5.8099
52-Wochen-Spanne:
Value
$3.305
$7.11

Goodrx Holdings Inc Stock (GDRX) Company Profile

Name
Firmenname
Goodrx Holdings Inc
Name
Telefon
(855) 268-2822
Name
Adresse
2701 OLYMPIC BOULEVARD, SANTA MONICA
Name
Mitarbeiter
738
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
GDRX's Discussions on Twitter

Vergleichen Sie GDRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
GDRX
Goodrx Holdings Inc
4.14 1.45B 775.09M -58.68M 64.06M -0.1326
Health Information Services icon
VEEV
Veeva Systems Inc
287.65 46.89B 2.97B 809.93M 1.33B 4.8743
Health Information Services icon
TEM
Tempus Ai Inc
89.87 16.41B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
67.03 12.64B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
94.04 8.03B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
36.62 6.90B 906.14M -52.62M 89.62M -0.3621

Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-11 Herabstufung Raymond James Strong Buy → Outperform
2024-12-04 Eingeleitet Mizuho Neutral
2024-08-09 Hochstufung Raymond James Outperform → Strong Buy
2024-05-23 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2024-05-16 Hochstufung Raymond James Mkt Perform → Outperform
2024-04-10 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2024-03-25 Hochstufung Wells Fargo Equal Weight → Overweight
2024-03-01 Hochstufung JP Morgan Neutral → Overweight
2024-02-26 Eingeleitet Leerink Partners Outperform
2024-01-02 Herabstufung BofA Securities Buy → Underperform
2023-08-10 Hochstufung DA Davidson Neutral → Buy
2023-07-31 Hochstufung TD Cowen Market Perform → Outperform
2022-12-01 Eingeleitet Citigroup Buy
2022-11-04 Hochstufung JP Morgan Underweight → Neutral
2022-09-16 Eingeleitet KeyBanc Capital Markets Sector Weight
2022-09-07 Eingeleitet Truist Hold
2022-08-12 Eingeleitet DA Davidson Neutral
2022-06-10 Herabstufung Goldman Buy → Neutral
2022-06-06 Fortgesetzt BofA Securities Buy
2022-06-01 Herabstufung Robert W. Baird Outperform → Neutral
2022-05-10 Herabstufung Evercore ISI Outperform → In-line
2022-05-10 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2022-05-10 Herabstufung Raymond James Outperform → Mkt Perform
2022-05-10 Herabstufung SVB Leerink Outperform → Mkt Perform
2022-04-11 Eingeleitet Wells Fargo Equal Weight
2022-04-07 Eingeleitet Guggenheim Buy
2022-04-01 Fortgesetzt Credit Suisse Neutral
2022-03-15 Hochstufung Robert W. Baird Neutral → Outperform
2022-03-01 Bestätigt Barclays Overweight
2022-03-01 Bestätigt BofA Securities Neutral
2022-03-01 Herabstufung Cowen Outperform → Market Perform
2022-03-01 Herabstufung Credit Suisse Outperform → Neutral
2022-03-01 Bestätigt Evercore ISI Outperform
2022-03-01 Bestätigt Goldman Buy
2022-03-01 Bestätigt JP Morgan Underweight
2022-03-01 Bestätigt RBC Capital Mkts Outperform
2022-03-01 Bestätigt SVB Leerink Outperform
2022-01-07 Eingeleitet Goldman Buy
2021-12-21 Eingeleitet Stephens Overweight
2021-12-02 Eingeleitet Jefferies Buy
2021-08-31 Hochstufung Barclays Equal Weight → Overweight
2021-08-13 Hochstufung Raymond James Mkt Perform → Outperform
2021-05-28 Eingeleitet Robert W. Baird Neutral
2021-04-06 Fortgesetzt Evercore ISI Outperform
2021-01-25 Eingeleitet Guggenheim Buy
2020-11-19 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2020-11-18 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-10-19 Eingeleitet Barclays Equal Weight
2020-10-19 Eingeleitet BofA Securities Neutral
2020-10-19 Eingeleitet Citigroup Buy
2020-10-19 Eingeleitet Cowen Outperform
2020-10-19 Eingeleitet Credit Suisse Outperform
2020-10-19 Eingeleitet Deutsche Bank Hold
2020-10-19 Eingeleitet Goldman Neutral
2020-10-19 Eingeleitet JP Morgan Neutral
2020-10-19 Eingeleitet Morgan Stanley Overweight
2020-10-19 Eingeleitet RBC Capital Mkts Sector Perform
2020-10-19 Eingeleitet SVB Leerink Outperform
2020-10-19 Eingeleitet UBS Buy
Alle ansehen

Goodrx Holdings Inc Aktie (GDRX) Neueste Nachrichten

pulisher
04:50 AM

How to use a screener to detect GoodRx Holdings Inc. breakoutsForecast Cut & Expert Curated Trade Ideas - newser.com

04:50 AM
pulisher
02:08 AM

Real time social sentiment graph for GoodRx Holdings Inc.Quarterly Profit Report & Technical Entry and Exit Tips - newser.com

02:08 AM
pulisher
Oct 13, 2025

How analysts rate GoodRx Holdings Inc. stock todayWeekly Investment Recap & Weekly High Conviction Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Institutional scanner results for GoodRx Holdings Inc.Weekly Market Report & Free High Return Stock Watch Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How sentiment analysis helps forecast GoodRx Holdings Inc.CEO Change & Accurate Intraday Trade Tips - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What Fibonacci levels say about GoodRx Holdings Inc. rebound2025 Major Catalysts & High Conviction Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Will GoodRx Holdings Inc. stock recover after recent dropTrade Volume Summary & Detailed Earnings Play Strategies - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

GoodRx (NASDAQ:GDRX) Sees Large Volume IncreaseShould You Buy? - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

GoodRx (NASDAQ:GDRX) Shares Up 10.5%Here's Why - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

GoodRx Holdings Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & Free High Velocity Capital Growth - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know - The Globe and Mail

Oct 10, 2025
pulisher
Oct 10, 2025

GoodRx: Novo Deal And TrumpRx Talks Point To EBITDA/FCF Upside (NASDAQ:GDRX) - Seeking Alpha

Oct 10, 2025
pulisher
Oct 10, 2025

Price action breakdown for GoodRx Holdings Inc.Quarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What technical models suggest about GoodRx Holdings Inc.’s comebackPortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

GoodRx’s Stock Soars: What’s Behind the Uptick? - timothysykes.com

Oct 09, 2025
pulisher
Oct 09, 2025

BofA Securities maintains Underperform rating on GoodRx stock amid TrumpRx uncertainty - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

GoodRx (GDRX) Faces Uncertain Impact from Potential TrumpRx Coll - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Trump Administration Engages Pharmacies, GoodRx For TrumpRx LaunchGoodRx Holdings (NASDAQ:GDRX) - Benzinga

Oct 09, 2025
pulisher
Oct 09, 2025

BofA on GoodRx Holdings Inc. (GDRX): 'We don’t have a strong view at this time on the potential upside/downside from TrumpRx' - StreetInsider

Oct 09, 2025
pulisher
Oct 09, 2025

GoodRx (GDRX) Shares Surge as Talks with White House Progress - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

GoodRx: Game-Changer Partnerships on the Horizon? - StocksToTrade

Oct 09, 2025
pulisher
Oct 09, 2025

GoodRx stock surges as company discusses TrumpRx role with administration - Investing.com Nigeria

Oct 09, 2025
pulisher
Oct 09, 2025

GoodRx stock spikes on plans to join TrumpRx (GDRX:NASDAQ) - Seeking Alpha

Oct 09, 2025
pulisher
Oct 09, 2025

Candlestick signals on GoodRx Holdings Inc. stock todayBull Run & Growth-Oriented Investment Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What machine learning models say about GoodRx Holdings Inc.Portfolio Value Summary & Accurate Buy Signal Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

GoodRx (NASDAQ:GDRX) Earns Hold (C-) Rating from Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 08, 2025

GoodRx Holdings, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo

Oct 08, 2025
pulisher
Oct 08, 2025

GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call - The Joplin Globe

Oct 08, 2025
pulisher
Oct 08, 2025

News - FinancialContent

Oct 08, 2025
pulisher
Oct 08, 2025

GoodRx (GDRX) Faces Industry Changes Amid BlinkRx Developments - GuruFocus

Oct 08, 2025
pulisher
Oct 06, 2025

Q2 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks - The Globe and Mail

Oct 06, 2025
pulisher
Oct 06, 2025

GoodRx (GDRX) Cuts Cost of Repatha to Boost Patient Savings - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

GoodRx expands affordable access to Repatha® with nearly 60% savings - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

Can trapped investors hope for a rebound in GoodRx Holdings Inc.Market Growth Review & Capital Protection Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

$239 cash price for Repatha — GoodRx expands access with nearly 60% savings at 70,000+ pharmacies - Stock Titan

Oct 06, 2025
pulisher
Oct 05, 2025

Can you recover from losses in GoodRx Holdings Inc.Portfolio Performance Report & Long-Term Capital Growth Strategies - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is GoodRx Holdings Inc. stock entering bullish territoryShare Buyback & Safe Entry Point Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

GoodRx Holdings Inc. (GDRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Oct 03, 2025
pulisher
Oct 03, 2025

Why GoodRx (GDRX) Stock Is Up Today - The Globe and Mail

Oct 03, 2025
pulisher
Oct 03, 2025

GoodRx (GDRX): Evaluating the Stock’s Valuation After Recent Share Price Volatility - Yahoo Finance

Oct 03, 2025
pulisher
Oct 03, 2025

How to recover losses in GoodRx Holdings Inc. stockWeekly Stock Summary & Entry Point Confirmation Signals - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What’s the recovery path for long term holders of GoodRx Holdings Inc.Quarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is GoodRx Holdings Inc. stock a buy for dividend growthPrice Action & Weekly Market Pulse Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

GoodRx Target of Unusually High Options Trading (NASDAQ:GDRX) - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Should You Think About Buying GoodRx Holdings, Inc. (NASDAQ:GDRX) Now? - simplywall.st

Oct 02, 2025
pulisher
Oct 02, 2025

What analysts say about GoodRx Holdings Inc stockStock Buyback Announcements & Low Risk Capital Appreciation - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

GoodRx stock surges on potential TrumpRx partnership and Kroger expansion - Investing.com

Oct 02, 2025
pulisher
Oct 01, 2025

GoodRx (GDRX) Stock Climbs as Citi Reaffirms Buy Rating - GuruFocus

Oct 01, 2025
pulisher
Oct 01, 2025

GoodRx (GDRX) Shares Surge 19% After CEO's Comments - GuruFocus

Oct 01, 2025
pulisher
Oct 01, 2025

GoodRx (GDRX) Shares Rise on Potential Inclusion in TrumpRx Init - GuruFocus

Oct 01, 2025
pulisher
Oct 01, 2025

GoodRx gains with late session surge on CEO remarks; closes up 19% - Seeking Alpha

Oct 01, 2025

Finanzdaten der Goodrx Holdings Inc-Aktie (GDRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$11.90
price down icon 2.86%
$28.00
price up icon 0.14%
$34.62
price up icon 4.21%
$24.81
price up icon 2.78%
$29.92
price up icon 1.49%
health_information_services WAY
$36.62
price up icon 1.26%
Kapitalisierung:     |  Volumen (24h):